NPR

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.

Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That's an urgent but daunting challenge in Michigan, where hospitals are struggling to keep up with a surge in new cases.

Monoclonal antibodies can hold the coronavirus in check by mimicking the body's natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency authorization for people over 65, as well as others with certain underlying health conditions.

On Wednesday, Michigan Gov. Gretchen Whitmer urged people in her

Вы читаете отрывок, зарегистрируйтесь, чтобы читать полное издание.

Другое от: NPR

NPR3 мин. чтения
'The Most Beautiful Girl In Cuba' Steps Out Of The Headlines And Onto The Page
The Spanish-American war serves as the backdrop for Chanel Cleeton's new novel, which follows a real-life rebel named Evangelina Cisneros, who attracted a lot of attention from American newspapers.
NPR2 мин. чтенияCrime & Violence
California Man Arrested In Suspected Fake COVID-19 Vaccine Card Operation
Undercover agents bought the fake cards for $20 each at a bar near Stockton. Authorities say they it's the first time they've seen this kind of forgery. Meanwhile, phony cards circulate online.
NPR4 мин. чтения
David Swensen, The Greatest Investor You Maybe Never Heard Of, Leaves Powerful Legacy
David Swensen made billions for Yale and revolutionized the way Universities and other non-profits invest. And he strove to teach everyday people how to invest without getting fleeced by Wall Street.